218 related articles for article (PubMed ID: 28815390)
1. Abnormal relationships between local and global brain measures in subjects at clinical high risk for psychosis: a pilot study.
Konishi J; Del Re EC; Bouix S; Blokland GAM; Mesholam-Gately R; Woodberry K; Niznikiewicz M; Goldstein J; Hirayasu Y; Petryshen TL; Seidman LJ; Shenton ME; McCarley RW
Brain Imaging Behav; 2018 Aug; 12(4):974-988. PubMed ID: 28815390
[TBL] [Abstract][Full Text] [Related]
2. Association of Adverse Outcomes With Emotion Processing and Its Neural Substrate in Individuals at Clinical High Risk for Psychosis.
Modinos G; Kempton MJ; Tognin S; Calem M; Porffy L; Antoniades M; Mason A; Azis M; Allen P; Nelson B; McGorry P; Pantelis C; Riecher-Rössler A; Borgwardt S; Bressan R; Barrantes-Vidal N; Krebs MO; Nordentoft M; Glenthøj B; Ruhrmann S; Sachs G; Rutten B; van Os J; de Haan L; Velthorst E; van der Gaag M; Valmaggia LR; McGuire P;
JAMA Psychiatry; 2020 Feb; 77(2):190-200. PubMed ID: 31722018
[TBL] [Abstract][Full Text] [Related]
3. Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group Mega-analysis.
; Jalbrzikowski M; Hayes RA; Wood SJ; Nordholm D; Zhou JH; Fusar-Poli P; Uhlhaas PJ; Takahashi T; Sugranyes G; Kwak YB; Mathalon DH; Katagiri N; Hooker CI; Smigielski L; Colibazzi T; Via E; Tang J; Koike S; Rasser PE; Michel C; Lebedeva I; Hegelstad WTV; de la Fuente-Sandoval C; Waltz JA; Mizrahi R; Corcoran CM; Resch F; Tamnes CK; Haas SS; Lemmers-Jansen ILJ; Agartz I; Allen P; Amminger GP; Andreassen OA; Atkinson K; Bachman P; Baeza I; Baldwin H; Bartholomeusz CF; Borgwardt S; Catalano S; Chee MWL; Chen X; Cho KIK; Cooper RE; Cropley VL; Dolz M; Ebdrup BH; Fortea A; Glenthøj LB; Glenthøj BY; de Haan L; Hamilton HK; Harris MA; Haut KM; He Y; Heekeren K; Heinz A; Hubl D; Hwang WJ; Kaess M; Kasai K; Kim M; Kindler J; Klaunig MJ; Koppel A; Kristensen TD; Kwon JS; Lawrie SM; Lee J; León-Ortiz P; Lin A; Loewy RL; Ma X; McGorry P; McGuire P; Mizuno M; Møller P; Moncada-Habib T; Muñoz-Samons D; Nelson B; Nemoto T; Nordentoft M; Omelchenko MA; Oppedal K; Ouyang L; Pantelis C; Pariente JC; Raghava JM; Reyes-Madrigal F; Roach BJ; Røssberg JI; Rössler W; Salisbury DF; Sasabayashi D; Schall U; Schiffman J; Schlagenhauf F; Schmidt A; Sørensen ME; Suzuki M; Theodoridou A; Tomyshev AS; Tor J; Værnes TG; Velakoulis D; Venegoni GD; Vinogradov S; Wenneberg C; Westlye LT; Yamasue H; Yuan L; Yung AR; van Amelsvoort TAMJ; Turner JA; van Erp TGM; Thompson PM; Hernaus D
JAMA Psychiatry; 2021 Jul; 78(7):753-766. PubMed ID: 33950164
[TBL] [Abstract][Full Text] [Related]
4. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
[TBL] [Abstract][Full Text] [Related]
5. Amygdala subnucleus volumes in psychosis high-risk state and first-episode psychosis.
Armio RL; Laurikainen H; Ilonen T; Walta M; Salokangas RKR; Koutsouleris N; Hietala J; Tuominen L
Schizophr Res; 2020 Jan; 215():284-292. PubMed ID: 31744752
[TBL] [Abstract][Full Text] [Related]
6. Ventricular enlargement and progressive reduction of cortical gray matter are linked in prodromal youth who develop psychosis.
Chung Y; Haut KM; He G; van Erp TGM; McEwen S; Addington J; Bearden CE; Cadenhead K; Cornblatt B; Mathalon DH; McGlashan T; Perkins D; Seidman LJ; Tsuang M; Walker E; Woods SW; Cannon TD;
Schizophr Res; 2017 Nov; 189():169-174. PubMed ID: 28245961
[TBL] [Abstract][Full Text] [Related]
7. Differences and similarities in insular and temporal pole MRI gray matter volume abnormalities in first-episode schizophrenia and affective psychosis.
Kasai K; Shenton ME; Salisbury DF; Onitsuka T; Toner SK; Yurgelun-Todd D; Kikinis R; Jolesz FA; McCarley RW
Arch Gen Psychiatry; 2003 Nov; 60(11):1069-77. PubMed ID: 14609882
[TBL] [Abstract][Full Text] [Related]
8. Hippocampal volume in normal aging and traumatic brain injury.
Bigler ED; Blatter DD; Anderson CV; Johnson SC; Gale SD; Hopkins RO; Burnett B
AJNR Am J Neuroradiol; 1997 Jan; 18(1):11-23. PubMed ID: 9010515
[TBL] [Abstract][Full Text] [Related]
9. Correlations between ventricular enlargement and gray and white matter volumes of cortex, thalamus, striatum, and internal capsule in schizophrenia.
Horga G; Bernacer J; Dusi N; Entis J; Chu K; Hazlett EA; Haznedar MM; Kemether E; Byne W; Buchsbaum MS
Eur Arch Psychiatry Clin Neurosci; 2011 Oct; 261(7):467-76. PubMed ID: 21431919
[TBL] [Abstract][Full Text] [Related]
10. Reduced amygdala and hippocampal volumes in patients with methamphetamine psychosis.
Orikabe L; Yamasue H; Inoue H; Takayanagi Y; Mozue Y; Sudo Y; Ishii T; Itokawa M; Suzuki M; Kurachi M; Okazaki Y; Kasai K
Schizophr Res; 2011 Nov; 132(2-3):183-9. PubMed ID: 21784619
[TBL] [Abstract][Full Text] [Related]
11. Neuroanatomical abnormalities that predate the onset of psychosis: a multicenter study.
Mechelli A; Riecher-Rössler A; Meisenzahl EM; Tognin S; Wood SJ; Borgwardt SJ; Koutsouleris N; Yung AR; Stone JM; Phillips LJ; McGorry PD; Valli I; Velakoulis D; Woolley J; Pantelis C; McGuire P
Arch Gen Psychiatry; 2011 May; 68(5):489-95. PubMed ID: 21536978
[TBL] [Abstract][Full Text] [Related]
12. Cortical thinning and caudate abnormalities in first episode psychosis and their association with clinical outcome.
Scanlon C; Anderson-Schmidt H; Kilmartin L; McInerney S; Kenney J; McFarland J; Waldron M; Ambati S; Fullard A; Logan S; Hallahan B; Barker GJ; Elliott MA; McCarthy P; Cannon DM; McDonald C
Schizophr Res; 2014 Oct; 159(1):36-42. PubMed ID: 25124520
[TBL] [Abstract][Full Text] [Related]
13. White matter alterations related to P300 abnormalities in individuals at high risk for psychosis: an MRI-EEG study.
Fusar-Poli P; Crossley N; Woolley J; Carletti F; Perez-Iglesias R; Broome M; Johns L; Tabraham P; Bramon E; McGuire P
J Psychiatry Neurosci; 2011 Jul; 36(4):239-48. PubMed ID: 21299920
[TBL] [Abstract][Full Text] [Related]
14. HPA-axis function and grey matter volume reductions: imaging the diathesis-stress model in individuals at ultra-high risk of psychosis.
Valli I; Crossley NA; Day F; Stone J; Tognin S; Mondelli V; Howes O; Valmaggia L; Pariante C; McGuire P
Transl Psychiatry; 2016 May; 6(5):e797. PubMed ID: 27138796
[TBL] [Abstract][Full Text] [Related]
15. Developmentally stable whole-brain volume reductions and developmentally sensitive caudate and putamen volume alterations in those with attention-deficit/hyperactivity disorder and their unaffected siblings.
Greven CU; Bralten J; Mennes M; O'Dwyer L; van Hulzen KJ; Rommelse N; Schweren LJ; Hoekstra PJ; Hartman CA; Heslenfeld D; Oosterlaan J; Faraone SV; Franke B; Zwiers MP; Arias-Vasquez A; Buitelaar JK
JAMA Psychiatry; 2015 May; 72(5):490-9. PubMed ID: 25785435
[TBL] [Abstract][Full Text] [Related]
16. TSPO expression and brain structure in the psychosis spectrum.
Hafizi S; Guma E; Koppel A; Da Silva T; Kiang M; Houle S; Wilson AA; Rusjan PM; Chakravarty MM; Mizrahi R
Brain Behav Immun; 2018 Nov; 74():79-85. PubMed ID: 29906515
[TBL] [Abstract][Full Text] [Related]
17. Baseline Cortical Thickness Reductions in Clinical High Risk for Psychosis: Brain Regions Associated with Conversion to Psychosis Versus Non-Conversion as Assessed at One-Year Follow-Up in the Shanghai-At-Risk-for-Psychosis (SHARP) Study.
Del Re EC; Stone WS; Bouix S; Seitz J; Zeng V; Guliano A; Somes N; Zhang T; Reid B; Lyall A; Lyons M; Li H; Whitfield-Gabrieli S; Keshavan M; Seidman LJ; McCarley RW; Wang J; Tang Y; Shenton ME; Niznikiewicz MA
Schizophr Bull; 2021 Mar; 47(2):562-574. PubMed ID: 32926141
[TBL] [Abstract][Full Text] [Related]
18. White matter microstructure in individuals at clinical high risk of psychosis: a whole-brain diffusion tensor imaging study.
von Hohenberg CC; Pasternak O; Kubicki M; Ballinger T; Vu MA; Swisher T; Green K; Giwerc M; Dahlben B; Goldstein JM; Woo TU; Petryshen TL; Mesholam-Gately RI; Woodberry KA; Thermenos HW; Mulert C; McCarley RW; Seidman LJ; Shenton ME
Schizophr Bull; 2014 Jul; 40(4):895-903. PubMed ID: 23737549
[TBL] [Abstract][Full Text] [Related]
19. Cerebral grey, white matter and csf in never-medicated, first-episode schizophrenia.
Chua SE; Cheung C; Cheung V; Tsang JT; Chen EY; Wong JC; Cheung JP; Yip L; Tai KS; Suckling J; McAlonan GM
Schizophr Res; 2007 Jan; 89(1-3):12-21. PubMed ID: 17098398
[TBL] [Abstract][Full Text] [Related]
20. Relation between cannabis use and subcortical volumes in people at clinical high risk of psychosis.
Buchy L; Mathalon DH; Cannon TD; Cadenhead KS; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Addington J
Psychiatry Res Neuroimaging; 2016 Aug; 254():3-9. PubMed ID: 27289213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
